Who Owns Encompass Health Company?

Who Owns Encompass Health?

Understanding Encompass Health's ownership is key to grasping its strategic direction and market influence. The company, formerly HealthSouth Corporation, rebranded in 2018 to better reflect its expanded services.

Founded in 1984, Encompass Health has grown into a leading provider of inpatient rehabilitative services, with its headquarters still in Birmingham, Alabama.

As of 2024, Encompass Health operates 166 inpatient rehabilitation hospitals across 38 states and Puerto Rico. The company's market capitalization was approximately $10.9 billion as of August 1, 2025, with trailing twelve-month revenue reaching $5.51 billion. Analyzing its ownership reveals the interplay of founders, institutional investors, and public shareholders, influencing its trajectory, including its Encompass Health BCG Matrix.

Encompass Health, originally incorporated as Amcare, Inc. on February 22, 1984, in Birmingham, Alabama, was founded by Richard M. Scrushy and four other co-founders. Scrushy, who envisioned the company in 1983, served as its chairman and CEO until 2003, while the co-founders managed administrative functions.

Founding Vision

Richard M. Scrushy conceived the idea for the company in 1983. He aimed to establish a healthcare provider focused on rehabilitation services.

Initial Operations

The company opened its first outpatient rehabilitation facility in Little Rock, Arkansas, in early 1984. A second facility followed in Birmingham later that year.

Brand Evolution

In 1985, the company rebranded itself as HealthSouth Rehabilitation Corporation. This name change aimed to better reflect its growing presence in the rehabilitation sector.

Strategic Expansion

A pivotal early move was the acquisition of its first inpatient rehabilitation hospital in early 1986. This acquisition marked a significant step towards specializing in inpatient care.

Public Offering

The company went public with an initial public offering (IPO) on the Nasdaq in August 1986. This event facilitated broader public ownership and provided capital for expansion.

Early Ownership Structure

While specific initial equity distributions among the co-founders are not publicly detailed, the IPO in 1986 transitioned ownership towards the public market.

The early years of the company were characterized by strategic growth and a clear focus on rehabilitation services, laying the groundwork for its future development and market position. Understanding the Growth Strategy of Encompass Health provides context for its initial ownership structure and subsequent evolution.

Founding and Early Development

Amcare, Inc. was incorporated in February 1984 by Richard M. Scrushy and four co-founders. Scrushy, the primary visionary, led the company as chairman and CEO for two decades.

• Incorporated as Amcare, Inc. on February 22, 1984.
• Richard M. Scrushy was the primary founder and initial CEO.
• First facility opened in Little Rock, Arkansas, in early 1984.
• Changed name to HealthSouth Rehabilitation Corporation in 1985.
• Acquired first inpatient hospital in early 1986.
• Completed IPO on Nasdaq in August 1986.

Encompass Health's journey from its 1986 Nasdaq IPO to its current NYSE listing has been marked by strategic growth and significant structural changes. Key acquisitions, such as the $300 million purchase of National Medical Enterprise's facilities in 1993, dramatically expanded its footprint and revenue, solidifying its market leadership. The spin-off of its home health and hospice segment in 2022 further reshaped its corporate structure.

As a publicly traded entity on the NYSE, Encompass Health's ownership is distributed among various stakeholders, with institutional investors and mutual funds typically holding the largest stakes. As of August 1, 2025, the company boasts a market capitalization of $10.9 billion. The first quarter of 2025 demonstrated strong financial performance, with net operating revenue reaching $1.46 billion, an increase of 10.6% year-over-year. Adjusted earnings per share stood at $1.37, and the company revised its full-year 2025 revenue guidance upwards to between $5.85 billion and $5.93 billion, reflecting positive investor sentiment and confidence in its strategic direction.

Understanding Encompass Health's Stakeholder Landscape

Encompass Health's ownership is primarily held by institutional investors, reflecting broad confidence in its market position and financial outlook. The company's strategic decisions, including acquisitions and spin-offs, directly influence its ownership evolution.

• Institutional investors are key holders of Encompass Health stock.
• The company's market capitalization was $10.9 billion as of August 1, 2025.
• Q1 2025 net operating revenue was $1.46 billion, a 10.6% increase year-over-year.
• Full-year 2025 revenue guidance was raised to $5.85 billion - $5.93 billion.
• Understanding Mission, Vision & Core Values of Encompass Health provides context for its strategic direction.

The current Board of Directors for Encompass Health is instrumental in guiding the company's strategic direction and corporate governance. Key leadership roles include Greg Carmichael as Chairman of the Board, Mark Tarr as President and CEO, and Douglas E. Coltharp as CFO. While specific individual shareholdings are not publicly detailed, boards of this nature typically include independent directors and representatives of significant stakeholders.

As a publicly traded entity on the NYSE under the ticker EHC, Encompass Health generally adheres to a standard one-share-one-vote system. This structure means that each share of common stock typically confers one vote on matters put before shareholders, such as director elections and significant corporate decisions. There is no public indication of dual-class share structures or special voting rights that would concentrate control among specific individuals or groups, reinforcing a transparent approach to Encompass Health ownership.

Shareholder Influence and Corporate Actions

Shareholders exercise their voting power on key corporate matters. This was evident in May 2025 when stockholders approved the Encompass Health Corporation 2025 Omnibus Performance Incentive Plan at the annual meeting.

• Shareholder approval of incentive plans
• Voting power on corporate actions
• Election of board members
• Strategic decisions impacting Encompass Health stock ownership
• Focus on stable governance and expansion

The company's ongoing strategic initiatives, such as the development of new inpatient rehabilitation hospitals, suggest a stable governance framework. Understanding the Brief History of Encompass Health can also provide context for its current ownership structure and corporate governance practices. While specific details on activist investor activity are not prominent, the company's performance indicates a generally consistent approach to managing Encompass Health shareholders' interests.

Over the past three to five years, Encompass Health has undergone significant strategic shifts, most notably the spin-off of its home health and hospice division, Enhabit Home Health & Hospice, in July 2022. This move allowed Encompass Health to concentrate on its core inpatient rehabilitation hospital operations, altering its overall corporate structure and ownership landscape.

Encompass Health's strategic focus on inpatient rehabilitation has been supported by consistent financial growth. In 2024, the company reported an 11.9% increase in net operating revenue and a 13.7% rise in Adjusted EBITDA. The first quarter of 2025 saw revenue climb by 10.6% year-over-year to $1.46 billion, leading to an upward revision of full-year 2025 revenue projections to between $5.85 billion and $5.93 billion. The company's financial health is further underscored by a net leverage ratio of 2.1x as of March 31, 2025, and a substantial $458 million remaining under its stock repurchase program. These buybacks can consolidate ownership by reducing the number of outstanding shares, potentially increasing the stakes of remaining Encompass Health shareholders.

Financial Performance Highlights

Encompass Health's revenue grew by 11.9% in 2024 and 10.6% in Q1 2025. Adjusted EBITDA saw a 13.7% increase in 2024.

Strategic Capital Allocation

The company had $458 million available for stock repurchases as of March 31, 2025. This indicates a commitment to returning value to shareholders.

Market Outlook

Analysts project a potential upside of 22.21% as of July 28, 2025. This suggests a positive sentiment among market observers regarding Encompass Health's future performance.

Operational Footprint

As of March 31, 2025, Encompass Health operates 167 rehabilitation hospitals across 38 states and Puerto Rico. Approximately 66 of these facilities are structured as joint ventures.